Brand teams often suffer from a loss of institutional knowledge as brand managers get caught up in the constant leadership churn prevalent in the pharma industry. Companies that create and continuously run counter-generics task forces build ongoing experience that is invaluable as their products lose patent protection. Join lead author of our new Counter-Generics report, Ryan McGuire, as he presents key findings and case studies of successful near-term generics-defense strategy implementation. Backed with benchmarks and hard metrics, this webinar is designed to provide brand managers, directors and therapeutic area heads with the best practices for developing a successful generics-defense strategy.

Learn How the Use of Industry Analytics will Help You to:

* Implement short-term tactics that brand teams successfully employ with 2 or fewer years left on their patents.

* Employ counter-promotions and other tactics to protect their revenue streams against generics of competitor products.

* Focus your generics-defense efforts throughout a product’s lifecycle and the importance of starting early.

* Create and continuously run counter-generics task forces that build ongoing generics-defense experience.

* Develop a well-timed and well-executed generics-defense strategy.